These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 13088594)

  • 1. Puerperal thrombosis, treatment with tromexan, control of prothrombin activity according to Pedrazzini, Salvidio and F. Koller.
    SCHELLENBERG W
    Praxis; 1953 Jul; 42(29):599-601. PubMed ID: 13088594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pelentan therapy in puerperal thrombosis].
    SZINNYAI M; VARJASI F; TREIT S; HUNKA R
    Magy Noorv Lapja; 1955 Nov; 18(6):351-60. PubMed ID: 13287319
    [No Abstract]   [Full Text] [Related]  

  • 3. The control of prothrombin activity with tromexan therapy.
    WEINER M; SIMSON G; BURNS JJ; STEELE JM; BRODIE BB
    Am J Med; 1953 Jun; 14(6):689-93. PubMed ID: 13057878
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of lability factor on the effects of sodium salicylate and tromexan on prothrombin time].
    SERT AS
    Tip Fak Mecm; 1954; 17(3):434-9. PubMed ID: 13226361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of thrombosis with tromexan in puerperium].
    MERZ WR; CHRIST MA
    Schweiz Med Wochenschr; 1952 Feb; 82(8):196-7. PubMed ID: 14930727
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental and clinical results with Tromexan].
    WRIGHT IS; BURKE GE; SCARONE LA
    Med Welt (Stuttg); 1951 Nov; 20(47):1469-71. PubMed ID: 14910281
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombotic diseases, especially treatment with tromexan].
    LINDAHL O
    Sven Lakartidn; 1956 Jan; 53(4):185-98. PubMed ID: 13311786
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of tromexan and dicumarol on clotting time and prothrombin index].
    KRISTENSON A
    Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term treatment of some arteriopathies with tromexan.
    CASTRO CM; STRITZLER G
    Angiology; 1955 Oct; 6(5):442-61. PubMed ID: 13275752
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid].
    BELLER FK
    Z Geburtshilfe Gynakol; 1954; 141(2):194-223. PubMed ID: 13227050
    [No Abstract]   [Full Text] [Related]  

  • 13. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of thromboses and embolisms in obstetrics and gynecology with the liquemin-depot Roche and with tromexan].
    KONIG FE
    Schweiz Med Wochenschr; 1953 Jan; 83(2):40-4. PubMed ID: 13056543
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
    SCHIAVINA GP
    Minerva Ginecol; 1953 Feb; 5(3):20-1. PubMed ID: 13063225
    [No Abstract]   [Full Text] [Related]  

  • 16. The coagulation defect caused by tromexan therapy.
    DOUGLAS AS
    Clin Sci; 1955 Nov; 14(4):601-13. PubMed ID: 13270444
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylaxis of thrombosis with tromexan in closed fractures of the leg].
    GLOOR F; SIGG B
    Praxis; 1950 Sep; 39(39):839-40. PubMed ID: 14786168
    [No Abstract]   [Full Text] [Related]  

  • 18. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
    BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556
    [No Abstract]   [Full Text] [Related]  

  • 19. Mode of action of tromexan.
    HUNTER RB; TUDHOPE GR
    Lancet; 1953 Apr; 1(6765):821-3. PubMed ID: 13036185
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of ethyl biscoumacetate (tromexan).
    VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA
    Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.